Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Veklury
Pharma
Gilead touts growth for HIV, cancer groups amid Veklury's fall
Even as sales of Gilead Sciences' COVID drug slow, the company was able to celebrate growth for its core offerings in 2022.
Zoey Becker
Feb 3, 2023 1:49pm
NICE advises against Merck's Lagevrio, AZ's Evusheld, 3 others
Nov 16, 2022 10:43am
Gilead plots pivotal clinical trial for COVID oral antiviral
Oct 19, 2022 12:01am
AZ gets key blessing in EU for Evusheld to treat COVID patients
Sep 16, 2022 10:50am
Gilead, despite setbacks, sees commercial momentum in oncology
Aug 3, 2022 9:20am
Lilly's Olumiant gets full FDA nod for COVID patients on oxygen
May 11, 2022 8:50am
